← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2013Last known activity
Aug 14, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 4 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (8)
- NCT06577311Sponsor investigatorPhase 2Aug 14, 2024
- NCT06577311Lead sponsorPhase 2Aug 14, 2024
- NCT06159842Lead sponsorPhase 2Aug 8, 2023
- NCT06159842Reponsible party - principal investigatorPhase 2Aug 8, 2023
- NCT03703895Reponsible party - principal investigatorPhase 4Sep 18, 2018
- NCT03703895Lead sponsorPhase 4Sep 18, 2018
- NCT03703895Overall official - principal investigatorPhase 4Sep 18, 2018
- NCT01910831Lead sponsorPhase 4Jul 1, 2013
Details
- Last known activity
- Aug 14, 2024